164 related articles for article (PubMed ID: 22609202)
1. Endoplasmic reticulum stress and the on site function of resident PTP1B.
Popov D
Biochem Biophys Res Commun; 2012 Jun; 422(4):535-8. PubMed ID: 22609202
[TBL] [Abstract][Full Text] [Related]
2. Endoplasmic reticulum stress, obesity and diabetes.
Cnop M; Foufelle F; Velloso LA
Trends Mol Med; 2012 Jan; 18(1):59-68. PubMed ID: 21889406
[TBL] [Abstract][Full Text] [Related]
3. Astragalus polysaccharides decreased the expression of PTP1B through relieving ER stress induced activation of ATF6 in a rat model of type 2 diabetes.
Wang N; Zhang D; Mao X; Zou F; Jin H; Ouyang J
Mol Cell Endocrinol; 2009 Aug; 307(1-2):89-98. PubMed ID: 19524131
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the protein tyrosine phosphatase PTP1B: potential therapy for obesity, insulin resistance and type-2 diabetes mellitus.
Koren S; Fantus IG
Best Pract Res Clin Endocrinol Metab; 2007 Dec; 21(4):621-40. PubMed ID: 18054739
[TBL] [Abstract][Full Text] [Related]
5. Protein tyrosine phosphatase 1B (PTP1B) and obesity.
Cho H
Vitam Horm; 2013; 91():405-24. PubMed ID: 23374726
[TBL] [Abstract][Full Text] [Related]
6. Deletion of protein tyrosine phosphatase 1B obliterates endoplasmic reticulum stress-induced myocardial dysfunction through regulation of autophagy.
Wang S; Chen X; Nair S; Sun D; Wang X; Ren J
Biochim Biophys Acta Mol Basis Dis; 2017 Dec; 1863(12):3060-3074. PubMed ID: 28941626
[TBL] [Abstract][Full Text] [Related]
7. Protein tyrosine phosphatase 1B inhibition improves endoplasmic reticulum stress‑impaired endothelial cell angiogenic response: A critical role for cell survival.
Abdelsalam SS; Pasha M; El-Gamal H; Hasan M; Elrayess MA; Zeidan A; Korashy HM; Agouni A
Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34296297
[TBL] [Abstract][Full Text] [Related]
8. Protein tyrosine phosphatase 1B regulates endothelial endoplasmic reticulum stress; role in endothelial dysfunction.
Thiebaut PA; Delile E; Coquerel D; Brunel JM; Renet S; Tamion F; Richard V
Vascul Pharmacol; 2018 Oct; 109():36-44. PubMed ID: 29894845
[TBL] [Abstract][Full Text] [Related]
9. Novel protein tyrosine phosphatase 1B inhibitors: interaction requirements for improved intracellular efficacy in type 2 diabetes mellitus and obesity control.
Popov D
Biochem Biophys Res Commun; 2011 Jul; 410(3):377-81. PubMed ID: 21683066
[TBL] [Abstract][Full Text] [Related]
10. Prodrug delivery of novel PTP1B inhibitors to enhance insulin signalling.
Erbe DV; Klaman LD; Wilson DP; Wan ZK; Kirincich SJ; Will S; Xu X; Kung L; Wang S; Tam S; Lee J; Tobin JF
Diabetes Obes Metab; 2009 Jun; 11(6):579-88. PubMed ID: 19383031
[TBL] [Abstract][Full Text] [Related]
11. Targeting protein tyrosine phosphatase to enhance insulin action for the potential treatment of diabetes.
Kasibhatla B; Wos J; Peters KG
Curr Opin Investig Drugs; 2007 Oct; 8(10):805-13. PubMed ID: 17907056
[TBL] [Abstract][Full Text] [Related]
12. Protein-tyrosine phosphatase 1B substrates and metabolic regulation.
Bakke J; Haj FG
Semin Cell Dev Biol; 2015 Jan; 37():58-65. PubMed ID: 25263014
[TBL] [Abstract][Full Text] [Related]
13. Endoplasmic reticulum stress upregulates protein tyrosine phosphatase 1B and impairs glucose uptake in cultured myotubes.
Panzhinskiy E; Hua Y; Culver B; Ren J; Nair S
Diabetologia; 2013 Mar; 56(3):598-607. PubMed ID: 23178931
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological inhibition of protein tyrosine phosphatase 1B: a promising strategy for the treatment of obesity and type 2 diabetes mellitus.
Panzhinskiy E; Ren J; Nair S
Curr Med Chem; 2013; 20(21):2609-25. PubMed ID: 23627940
[TBL] [Abstract][Full Text] [Related]
15. Protein tyrosine phosphatase 1B inhibitors for diabetes.
Johnson TO; Ermolieff J; Jirousek MR
Nat Rev Drug Discov; 2002 Sep; 1(9):696-709. PubMed ID: 12209150
[TBL] [Abstract][Full Text] [Related]
16. Selective deficiency in endothelial PTP1B protects from diabetes and endoplasmic reticulum stress-associated endothelial dysfunction via preventing endothelial cell apoptosis.
Legeay S; Fautrat P; Norman JB; Antonova G; Kennard S; Bruder-Nascimento T; Patel VS; Faure S; Belin de Chantemèle EJ
Biomed Pharmacother; 2020 Jul; 127():110200. PubMed ID: 32417688
[TBL] [Abstract][Full Text] [Related]
17. Targeting phosphorylation of eukaryotic initiation factor-2α to treat human disease.
Fullwood MJ; Zhou W; Shenolikar S
Prog Mol Biol Transl Sci; 2012; 106():75-106. PubMed ID: 22340715
[TBL] [Abstract][Full Text] [Related]
18. Reduction of heart failure by pharmacological inhibition or gene deletion of protein tyrosine phosphatase 1B.
Gomez E; Vercauteren M; Kurtz B; Ouvrard-Pascaud A; Mulder P; Henry JP; Besnier M; Waget A; Hooft Van Huijsduijnen R; Tremblay ML; Burcelin R; Thuillez C; Richard V
J Mol Cell Cardiol; 2012 Jun; 52(6):1257-64. PubMed ID: 22446161
[TBL] [Abstract][Full Text] [Related]
19. New insights into ER stress-induced insulin resistance.
Flamment M; Hajduch E; Ferré P; Foufelle F
Trends Endocrinol Metab; 2012 Aug; 23(8):381-90. PubMed ID: 22770719
[TBL] [Abstract][Full Text] [Related]
20. Role of protein tyrosine phosphatase 1B in cardiovascular diseases.
Thiebaut PA; Besnier M; Gomez E; Richard V
J Mol Cell Cardiol; 2016 Dec; 101():50-57. PubMed ID: 27596049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
